A Study of Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease

Clinical trial NCT05016427 · UNKNOWN

Trial details

NCT number: NCT05016427
Sponsor: VTBIO Co. LTD
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2020-11-01
Primary completion: 2021-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.